KRAS — Drug Target
All drugs that target KRAS — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (1)
- RAS 2410 · Nan Chen,MD · RAS pathway inhibitor · Oncology
RAS 2410 is a selective inhibitor of the RAS pathway.